Cancer Surgery breast cancer surgeries mastectomies
Conditions
Interventions
Group(PB) given bubivacaine0.5%
Group(PBN 1) will be given bubivacaine0.5% plus 10 mg nalbuphine in 1ml,
Group(PBN 2)
Sponsors
Fayoum University hospitals
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Sixty )60( patients American Society of Anesthesiologist (ASA) physical status I/II/III females, aged (18-78) years, undergoing breast surgery will be studied.
Exclusion criteria
Exclusion criteria: Exclusion criteria included patients undergoing bilateral breast surgery or breast reconstruction; those having contra-indications for PVB, e.g., patient refusal, infection at injection site, anticoagulant therapy, abnormal coagulation profile, or hypersensitivity to LA; patients on chronic antiemetics or chronic pain medication; pregnant patients; central neuropathy, liver or renal impairment, drug or alcohol abusers, and those with psychiatric illnesses that would interfere with perception and assessment of pain and obese patients with a body mass index (BMI) >30 kg/m2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure was cumulative IV tramadol consumption over 24 h, pain scores at rest and active movement of ipsilateral arm. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will include intraoperative fentanyl requirements, TFR, bradycardia , hypotension, sedation scores, complications ( nausea. vomiting, pruritus), time to mobilize, time to discharge and patient satisfaction. | — |
Countries
Egypt
Contacts
Public ContactAtef Mohamed Sayed
Lecturer of Anesthesiology , Fayoum University, Faculty of medicine
Outcome results
None listed